{"id":"aceprometazine","rwe":[{"pmid":"24446836","year":"2014","title":"Meprobamate-induced fixed drug eruption.","finding":"","journal":"Current drug safety","studyType":"Clinical Study"},{"pmid":"22850107","year":"2012","title":"[Severe meprobamate poisoning: description of 146 cases in a French department].","finding":"","journal":"Therapie","studyType":"Clinical Study"},{"pmid":"16566781","year":"2006","title":"Abusive prescription of psychostimulants: a study of two cases.","finding":"","journal":"Journal of forensic sciences","studyType":"Clinical Study"},{"pmid":"9120531","year":"1997","title":"Risk of syncope in the elderly and consumption of drugs: a case-control study.","finding":"","journal":"Journal of clinical epidemiology","studyType":"Clinical Study"},{"pmid":"4406367","year":"1974","title":"Electro-encephalographic study on the action of the combination meprobamate-aceprometazine on various cerebral systems.","finding":"","journal":"Arzneimittel-Forschung","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"Active","category":"status"},{"label":"Insomnia","category":"indication"},{"label":"Antipsychotic Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Central Nervous System Depressants","category":"pharmacology"},{"label":"Dopamine Agents","category":"pharmacology"},{"label":"Dopamine Antagonists","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Psychotropic Drugs","category":"pharmacology"},{"label":"Tranquilizing Agents","category":"pharmacology"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:29:06.507957","allNames":"acepromethazine","offLabel":[],"synonyms":["aceprometazine","acepromethazine","aceprometazine maleate"],"timeline":[],"brandName":"Acepromethazine","ecosystem":[{"indication":"Insomnia","otherDrugs":[{"name":"amobarbital","slug":"amobarbital","company":""},{"name":"choline","slug":"choline","company":""},{"name":"daridorexant","slug":"daridorexant","company":"Idorsia Pharmaceuticals Ltd"},{"name":"diphenhydramine","slug":"diphenhydramine","company":"Mcneil Cons"}],"globalPrevalence":750000000}],"mechanism":{"target":"Histamine H1 receptor","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor","isPrimary":true,"activityType":"","activityValue":null}],"modality":"Small Molecule","explanation":"Imagine histamine as a key that unlocks a door in your brain, making you feel awake and alert. Acepromethazine is like a lock that blocks that key, preventing histamine from doing its job and helping you fall asleep. This allows you to get a good night's rest and feel more refreshed in the morning.","oneSentence":"Acepromethazine works by blocking histamine receptors in the brain to promote sleep.","technicalDetail":"Acepromethazine acts as a competitive antagonist at the histamine H1 receptor, inhibiting the binding of histamine and subsequent downstream signaling pathways involved in arousal and wakefulness."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/50","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACEPROMETAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:22:27.870312","biosimilars":[],"competitors":[{"drugName":"acrivastine","drugSlug":"acrivastine","fdaApproval":"1994-03-25","relationship":"same-target"},{"drugName":"alcaftadine","drugSlug":"alcaftadine","fdaApproval":"2010-07-28","patentExpiry":"Mar 19, 2027","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"alimemazine","drugSlug":"alimemazine","fdaApproval":"","relationship":"same-target"},{"drugName":"amitriptyline","drugSlug":"amitriptyline","fdaApproval":"1961-04-07","genericCount":33,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"amoxapine","drugSlug":"amoxapine","fdaApproval":"1980-09-22","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"antazoline","drugSlug":"antazoline","fdaApproval":"1990-04-30","relationship":"same-target"},{"drugName":"aripiprazole","drugSlug":"aripiprazole","fdaApproval":"2002-11-15","patentExpiry":"Sep 24, 2033","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"aripiprazole lauroxil","drugSlug":"aripiprazole-lauroxil","fdaApproval":"2015-10-05","patentExpiry":"Sep 8, 2035","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"asenapine","drugSlug":"asenapine","fdaApproval":"2009-08-13","patentExpiry":"Sep 22, 2033","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-target"}],"genericName":"aceprometazine","indications":{"approved":[{"name":"Insomnia","source":"DrugCentral","snomedId":193462001,"regulator":"FDA","usPrevalence":70000000,"globalPrevalence":750000000,"prevalenceMethod":"curated","prevalenceSource":"Sleep Medicine Reviews, 2023"}],"offLabel":[],"pipeline":[]},"_fixedFields":["primaryTarget","pubmed(5)"],"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"acrivastine","brandName":"acrivastine","genericName":"acrivastine","approvalYear":"1994","relationship":"same-target"},{"drugId":"alcaftadine","brandName":"alcaftadine","genericName":"alcaftadine","approvalYear":"2010","relationship":"same-target"},{"drugId":"alimemazine","brandName":"alimemazine","genericName":"alimemazine","approvalYear":"","relationship":"same-target"},{"drugId":"amitriptyline","brandName":"amitriptyline","genericName":"amitriptyline","approvalYear":"1961","relationship":"same-target"},{"drugId":"amoxapine","brandName":"amoxapine","genericName":"amoxapine","approvalYear":"1980","relationship":"same-target"},{"drugId":"antazoline","brandName":"antazoline","genericName":"antazoline","approvalYear":"1990","relationship":"same-target"},{"drugId":"aripiprazole","brandName":"aripiprazole","genericName":"aripiprazole","approvalYear":"2002","relationship":"same-target"},{"drugId":"aripiprazole-lauroxil","brandName":"aripiprazole lauroxil","genericName":"aripiprazole lauroxil","approvalYear":"2015","relationship":"same-target"},{"drugId":"asenapine","brandName":"asenapine","genericName":"asenapine","approvalYear":"2009","relationship":"same-target"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005488","UNII":"984N9YTM4Y","CHEBI":"CHEBI:53770","INN_ID":"1921","RXNORM":"161203","UMLSCUI":"C0608826","ChEMBL_ID":"CHEMBL2104054","DRUGBANK_ID":"DB01615","PUBCHEM_CID":"26035","SECONDARY_CAS_RN":"7455-18-7","MESH_SUPPLEMENTAL_RECORD_UI":"C021280"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":5,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[{"date":"2014","pmid":"24446836","title":"Meprobamate-induced fixed drug eruption.","journal":"Current drug safety"},{"date":"2012 Mar-Apr","pmid":"22850107","title":"[Severe meprobamate poisoning: description of 146 cases in a French department].","journal":"Therapie"},{"date":"2006 Mar","pmid":"16566781","title":"Abusive prescription of psychostimulants: a study of two cases.","journal":"Journal of forensic sciences"},{"date":"1997 Mar","pmid":"9120531","title":"Risk of syncope in the elderly and consumption of drugs: a case-control study.","journal":"Journal of clinical epidemiology"},{"date":"1974 Feb","pmid":"4406367","title":"Electro-encephalographic study on the action of the combination meprobamate-aceprometazine on various cerebral systems.","journal":"Arzneimittel-Forschung"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acepromethazine is a small molecule medication. It is also known by other names, including Aceprometazina, Aceprometazine, and CB 1664.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}